Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP
Report ID | 81678 |
Drug Identification Number | 02292270 |
Brand name | CEFTRIAXONE SODIUM FOR INJECTION BP |
Common or Proper name | CEFTRIAXONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CEFTRIAXONE |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10vials |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2019-04-18 |
Estimated end date | Unknown |
Actual end date | 2019-09-04 |
Shortage status | Resolved |
Updated date | 2019-09-10 |
Company comments | Limited supply . Stock available at some wholesalers/Inventaire disponible chez certains grossistes |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-09-10 | French | Compare |
v7 | 2019-09-10 | English | Compare |
v6 | 2019-05-07 | French | Compare |
v5 | 2019-05-07 | English | Compare |
v4 | 2019-04-19 | English | Compare |
v3 | 2019-04-15 | French | Compare |
v2 | 2019-04-15 | French | Compare |
v1 | 2019-04-15 | English | Compare |
Showing 1 to 8 of 8